25 results on '"Panitumumab -- Forecasts and trends"'
Search Results
2. Epidermal Growth Factor Receptor (EGFR) Inhibitors Market to grow by USD 6.75 billion from 2024 to 2028, North America to account for 40% of market growth- Technavio
3. Global Cancer Monoclonal Antibodies Market Report 2023: Players Include Amgen, Bristol Myers Squibb, Eli Lilly and Company, F. Hoffmann-La Roche and Genmab
4. Colorectal Cancer Drugs Global Market Report 2023: Sector to Reach $16.22 Billion in 2027 at a CAGR of 3.3%
5. Colorectal Cancer Drugs Global Market Report 2023
6. Cancer Monoclonal Antibodies Market Report 2022: Rising Preference for Personalized Medicines Provides Boost to Sector
7. Cancer Monoclonal Antibodies Market Report 2022: Widespread Adoption of Cost-Efficient Biosimilar Monoclonal Antibodies Driving Growth
8. Cancer Monoclonal Antibodies Market Report 2022: Widespread Adoption of Cost-Efficient Biosimilar Monoclonal Antibodies Driving Growth - ResearchAndMarkets.com
9. Global Colorectal Cancer Drugs Industry Analysis, 2022-2026, Featuring Merck & Co, Roche, Sanofi, Amgen, and Pfizer Among Others
10. Global $16.4B Colorectal Cancer Drugs Market Outlook, 2026 - Diagnosed Incident Cases Expected to Increase by 27.3%, to 672,400 Cases by 2037
11. Global Colorectal Cancer Drugs Industry Analysis, 2022-2026, Featuring Merck & Co, Roche, Sanofi, Amgen, and Pfizer Among Others - ResearchAndMarkets.com
12. Global $16.4B Colorectal Cancer Drugs Market Outlook, 2026 - Diagnosed Incident Cases Expected to Increase by 27.3%, to 672,400 Cases by 2037
13. Global Colorectal Cancer Drugs Industry Analysis, 2022-2026, Featuring Merck & Co, Roche, Sanofi, Amgen, and Pfizer Among Others
14. Global Cancer Monoclonal Antibodies Market Report 2022-2031: Major Players are BMS, Eli Lilly and Co, F. Hoffmann-La Roche, Genmab, GSK, Johnson & Johnson, Novartis, Merck and Spectrum
15. Global Cancer Monoclonal Antibodies Market Report 2022-2031: Major Players are BMS, Eli Lilly and Co, F. Hoffmann-La Roche, Genmab, GSK, Johnson & Johnson, Novartis, Merck and Spectrum - ResearchAndMarkets.com
16. Global Cancer Monoclonal Antibodies Market Report 2022-2031: Major Players are BMS, Eli Lilly and Co, F. Hoffmann-La Roche, Genmab, GSK, Johnson & Johnson, Novartis, Merck and Spectrum
17. Colorectal Cancer Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030 Following a 2.2% Decrease in 2021
18. Colorectal Cancer Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030 Following a 2.2% Decrease in 2021 - ResearchAndMarkets.com
19. Colorectal Cancer Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030 Following a 2.2% Decrease in 2021
20. Laryngeal Cancer Therapeutics Market to Grow by USD 635.07 Million during 2021-2025|Amgen Inc. and AstraZeneca Plc Emerge as Key Contributors to Growth |Technavio
21. Global Cancer Monoclonal Antibodies Market Report 2020-2030: COVID-19 Growth and Changes for the $45.4 Billion Industry - ResearchAndMarkets.com
22. Global Cancer Monoclonal Antibodies Market Report 2020-2030: COVID-19 Growth and Changes for the $45.4 Billion Industry
23. Cancer Monoclonal Antibodies Global Market Report 2020-30: COVID-19 Growth and Change
24. Cancer Monoclonal Antibodies Global Market Report 2020-30: COVID-19 Growth and Change
25. Global Cancer Monoclonal Antibodies Markets, 2020-2025
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.